Track your manuscript:


Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Special Offers






Abstracted/Indexed in




SCImago Journal Ranking

SCImago Journal & Country Rank

Forthcoming Special Issues

Applications of gold nanoparticles(GNPs) in cancer managements


Guest Editor(s): Ali Yadollahpour
Tentative Publication Date: May, 2017
Submit Abstract via Email Download Description
Special Issues - In-Press
Please visit again after some time to view these Issues.
Published Special Issues

The Use Of Positron Emission Tomography In External Beam Therapy Dose Planning


Current Radiopharmaceuticals, Volume 8, Number 1
Guest Editor(s): Kalevi Kairemo

Current Radiopharmaceuticals

,

Volume 11

-

Number 3



Biography   Open Access



Editorial   Open Access



Review Article   Open Access

Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 11(3): 156 - 172

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*


DOI: 10.2174/1874471011666180416161908




Review Article



Review Article



Review Article



Review Article   Open Access

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 11(3): 200 - 208

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524




Review Article



Articles Ahead of Print

Synthesis of [18F]FAZA Using Nosyl and Iodo Precursors for Nucleophilic Radiofluorination


William Sun, Cheryl Falzon, Ebrahim Naimi , Ali Akbari , Leonard I Wiebe*, Manju Tandon and Piyush Kumar


View Abstract View on PubMed



Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal Hemorrhage


Pierpaolo Alongi*, Ignazio Gaspare Vetrano, Elisa Fiasconaro, Valerio Alaimo, Riccardo Laudicella, Marina Bellavia, Francesca Rubino, Sergio Bagnato and Giuseppe Galardi


View Abstract View on PubMed


Evaluating the Radioprotective Effect of Curcumin on Rat’s Heart Tissues


Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa


View Abstract View on PubMed



Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice



Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?

, 2018; 11(2): 123 - 129

Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*


DOI: 10.2174/1874471011666180418110206



Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy

, 2018; 11(1): 34 - 45

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa


DOI: 10.2174/1874471011666171229123130




PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives

, 2017; 10(3): 184 - 194

Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*


DOI: 10.2174/1874471010666170816125051



β -[18F]Fluoro Azomycin Arabinoside (β -[18F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors

, 2017; 10(2): 93 - 101

Piyush Kumar*, Peter Roselt, Gerald Reischl, Carlene Cullinane, Davood Beiki, Walter Ehrlichmann, David Binns, Ebrahim Naimi, Jennifer Yang, Rodney Hicks, Hans-Juergen Machulla and Leonard I. Wiebe


DOI: 10.2174/1874471010666170313120540



Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders

, 2017; 10(2): 115 - 122

Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer


DOI: 10.2174/1874471010666170621122221



177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma

, 2017; 10(1): 21 - 28

Ximena Camacho, Victoria Calzada, Marcelo Fernandez, Omar Alonso, Roger Chammas, Eloisa Riva, Juan Pablo Gambini and Pablo Cabral


DOI: 10.2174/1874471009666161010155246




Open Access Articles

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 2018; 11(3): 200 - 208

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer




Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156 - 172

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*




Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level

, 2018; 11: 1 - 9 (E-Pub Ahead of Print)

I Kreimerman, E Mora-Ramirez , A. L Reyes, M Bardies , E Savio * and H Engler




Synthesis of [18F]2B-SRF101: A Sulfonamide Derivative of the Fluorescent Dye Sulforhodamine 101

, 2017; 10(3): 212 - 220

Ingrid Kreimerman, Williams Porcal, Silvia Olivera, Patricia Oliver, Eduardo Savio* and Henry Engler




Automated One-pot Radiosynthesis of [11C]S-adenosyl Methionine

, 2017; 10(3): 203 - 211

Florencia Zoppolo, Williams Porcal, Patricia Oliver, Eduardo Savio* and Henry Engler




Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders

, 2017; 10(2): 115 - 122

Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer




Gallium-68 in Medical Imaging

, 2016; 9(3): 187 - 207

Lucia Martiniova, Louis De Palatis, Elba Etchebehere and Gregory Ravizzini




Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

, 2013; 6(1): 20 - 27

Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle




Targeted α-Particle Therapy: A Clinical Overview

, 2008; 1(3): 251 - 253

Massimo Salvatori, Luca Indovina and Luigi Mansi




Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

, 2008; 1(3): 203 - 208

Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen




Increased [11C]Choline Uptake in Bronchioloalveolar Cell Carcinoma with Negative [18F]FDG Uptake. A PET/CT and Pathology Study

, 2008; 1(2): 62 - 64

Maria Picchio, C. Messa, B. Giglioni, F. Sanvito, E. Caporizzo, C. Landoni, G. Arrigoni, A. Carretta, R. Nicoletti, P. Zannini, A. Del Maschio and F. Fazio




Asymmetric Synthesis of L-[3-13C]Tryptophan

, 2008; 1(2): 122 - 124

Kazuhiko Takatori, Myonghui Lee and Masahiro Kajiwara






Most Cited Articles

Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody

, 2016; 9(1): 44-53.

Shankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S. Jhanwar, Gurveen Kaur, Scott T. Tagawa, David M. Nanus, Neil H. Bander and Stanley J. Goldsmith


DOI: 10.2174/1874471008666150313114005


Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with 177Lu and Conjugated to Peptides

, 2015; 8(2): 150-159.

Guillermina Ferro-Flores, Blanca E. Ocampo-García, Clara L. Santos-Cuevas, Flor de María Ramírez, Erika P. Azorín-Vega and Laura Meléndez-Alafort


DOI: 10.2174/1874471008666150313115423






Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176

, 2015; 8(2): 95-106.

Valery A. Tarasov, Oleg I. Andreev, Evgeny G. Romanov, Rostislav A. Kuznetsov, Vladimir V. Kupriyanov and Ivan V. Tselishchev


DOI: 10.2174/1874471008666150312160855


Overview of Development and Formulation of 177Lu-DOTA-TATE for PRRT

, 2016; 9(1): 8-18.

Wouter A.P. Breeman, Ho Sze Chan, Rory M.S. de Zanger, Mark K. Konijnenberg and Erik de Blois


DOI: 10.2174/1874471008666150313111131


Planning of External Beam Radiotherapy for Prostate Cancer Guided by PET/CT

, 2015; 8(1): 19-31.

Finn Edler von Eyben, Kalevi Kairemo, Timo Kiljunen and Timo Joensuu


DOI: 10.2174/1874471008666150316222203


Evaluation of a Labelled Bacteriophage with 99mTc as a Potential Agent for Infection Diagnosis

, 2016; 9(2): 137-142.

María Elena Cardoso, Leticia Fernández, Emilia Tejería, Patricia Esperón and Mariella Terán


DOI: 10.2174/1874471009666160215162023



Most Accessed Articles

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 2018; 11(3): 200-208.

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524



Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy

, 2018; 11(1): 34-45.

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa


DOI: 10.2174/1874471011666171229123130


Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156-172.

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*


DOI: 10.2174/1874471011666180416161908


PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications

, 2018; 11(1): 4-13.

Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello


DOI: 10.2174/1874471010666171101121803



Letter to the Editor: International Consensus Radiochemistry Nomenclature Guidelines

, 2018; 11(1): 73-75.

Heinz H. Coenen*, Antony D. Gee*, Michael Adam, Gunnar Antoni, Cathy S. Cutler, Yasuhisa Fujibayashi, Jae Min Jeong, Robert H. Mach, Thomas L. Mindt, Victor W. Pike and Albert D. Windhorst


DOI: 10.2174/187447101101180404111248


Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings

, 2018; 11(1): 22-33.

Giulia Anna Follacchio*, Maria Silvia De Feo, Giuseppe De Vincentis, Francesco Monteleone and Mauro Liberatore


DOI: 10.2174/1874471011666171211161851




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science | Privacy Policy